AstraZeneca

Oxford Biomedica signs new deal to make AstraZeneca COVID shot

Read more

AstraZeneca gets EU backing for targetted breast cancer therapies

Read more

AstraZeneca India extends programme on cancer-screening for women in TN

Read more

AstraZeneca and Ionis eye US approval after positive trial data

Read more

Researchers identify rise in Guillain-Barre syndrome following AstraZeneca vaccine

Read more

Dapagliflozin meets primary endpoint in Deliver phase-III trial

Read more

Existing AstraZeneca drug may reduce damage after spinal cord injury

Read more

AstraZeneca boosts COVID portfolio with RQ Bio deal

Read more

AstraZeneca COVID booster shot effective against severe disease, finds UK study

Read more

AstraZeneca says its COVID shot has market potential despite lower demand

Read more